Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Bilcare
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 246 | 234 | 182 | 190 | 175 | 200 | 194 | 202 | 198 | 194 | 186 | 178 | 181 |
| Expenses + | 234 | 219 | 169 | 173 | 158 | 208 | 175 | 194 | 187 | 187 | 175 | 175 | 168 |
| Operating Profit | 12 | 14 | 13 | 17 | 17 | -8 | 19 | 8 | 11 | 7 | 11 | 3 | 13 |
| OPM % | 5% | 6% | 7% | 9% | 10% | -4% | 10% | 4% | 5% | 4% | 6% | 2% | 7% |
| Other Income + | -6 | 231 | 3 | 1 | 4 | 9 | 4 | -6 | -6 | 21 | 6 | 4 | 3 |
| Interest | 16 | 11 | 19 | 20 | 21 | 23 | 21 | 24 | 19 | 18 | 19 | 19 | 17 |
| Depreciation | 10 | 9 | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 12 | 12 | 12 | 12 |
| Profit before tax | -20 | 225 | -13 | -13 | -10 | -35 | -10 | -33 | -27 | -2 | -13 | -24 | -13 |
| Tax % | -6% | 65% | -1% | -5% | 34% | -44% | 55% | -10% | -40% | -432% | -25% | -1% | 2% |
| Net Profit + | -19 | 78 | -13 | -12 | -14 | -20 | -15 | -30 | -16 | 5 | -10 | -23 | -13 |
| EPS in Rs | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.04 | 4.48 | -1.61 | -5.25 | -2.53 |
Financials of Bilcare
Annual income statement trend
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 740 |
| Expenses + | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 705 |
| Operating Profit | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 35 |
| OPM % | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 6% | 5% |
| Other Income + | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 35 |
| Interest | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 73 |
| Depreciation | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 47 |
| Profit before tax | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -51 |
| Tax % | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | |
| Net Profit + | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -41 |
| EPS in Rs | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | -4.91 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Bilcare
Capital structure and asset base
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,300 | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 445 | 430 |
| Borrowings + | 2,146 | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 682 | 672 |
| Other Liabilities + | 899 | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 266 | 255 |
| Total Liabilities | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
| Fixed Assets + | 2,126 | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 949 | 930 |
| CWIP | 262 | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 | 7 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 14 |
| Other Assets + | 1,979 | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 | 429 |
| Total Assets | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
Financials of Bilcare
Operating, investing and financing cash movement
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 314 | -315 | 177 | 300 | 98 | 206 | 256 | 72 | 41 | -7 | 62 | 85 |
| Cash from Investing Activity + | -351 | 247 | -358 | -129 | -203 | -104 | 1,309 | 2 | -4 | 36 | -106 | 81 |
| Cash from Financing Activity + | 48 | 119 | 149 | -155 | 91 | -103 | -1,600 | -83 | -55 | -19 | 36 | -169 |
| Net Cash Flow | 12 | 50 | -32 | 16 | -13 | -1 | -35 | -9 | -18 | 10 | -7 | -3 |
| Free Cash Flow | -59 | -74 | -12 | 165 | -115 | 91 | 1,569 | 69 | 37 | 11 | -34 | 140 |
| CFO/OP | 121% | -170% | 85% | 173% | 75% | 148% | 828% | 141% | 78% | -6% | 162% | 193% |
Financials of Bilcare
Working capital efficiency and return ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 |
| Inventory Days | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 |
| Days Payable | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 |
| Cash Conversion Cycle | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 |
| Working Capital Days | 114 | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 |
| ROCE % | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% |
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…